Results
1 -
2 of
2Axten Jeffrey M., Medina Jesús R., Feng Yanhong, Shu Arthur, Romeril Stuart P., Grant Seth W., Li William Hoi Hong, Heerding Dirk A., Minthorn Elisabeth, Mencken Thomas, Atkins Charity, Liu Qi, Rabindran Sridhar, Kumar Rakesh, Hong Xuan, Goetz Aaron, Stanley Thomas, Taylor J. David, Sigethy Scott D., Tomberlin Ginger H., Hassell Annie M., Kahler Kirsten M., Shewchuk Lisa M., Gampe Robert T..
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK), Journal of Medicinal Chemistry, 2012 Moreno J. A., Halliday M., Molloy C., Radford H., Verity N., Axten J. M., Ortori C. A., Willis A. E., Fischer P. M., Barrett D. A., Mallucci G. R..
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice, Science Translational Medicine, 2013